DIAJARD M 12.5/1000MG TAB 14s

DIAJARD M 12.5/1000MG Tablets is an oral antidiabetic medication used for the management of Type 2 Diabetes Mellitus. It combines two effective ingredients — Empagliflozin (12.5mg) and Metformin (1000mg) — which work synergistically to lower blood glucose levels, improve insulin sensitivity, and enhance overall glycemic control. This dual-action formula not only helps control blood sugar but also supports weight management and heart health in diabetic patients.

Uses:

• Helps manage Type 2 Diabetes Mellitus in adults

• Reduces blood glucose levels by targeting multiple mechanisms

• Improves insulin sensitivity and glucose utilization

• Decreases hepatic glucose production and promotes urinary glucose excretion

• Supports weight loss and helps prevent diabetes-related complications

Benefits:

• Empagliflozin (12.5mg): Works as an SGLT2 inhibitor, helping remove excess glucose through urine

• Metformin (1000mg): Reduces glucose production in the liver and enhances insulin response

• Dual mechanism ensures comprehensive and effective glucose control

• Helps reduce cardiovascular and renal risk associated with diabetes

• May contribute to weight reduction and better metabolic balance

• Convenient once or twice daily dosage as directed by your physician

Possible Side Effects:

• Common: Increased urination, nausea, diarrhea, or mild stomach discomfort

• Occasional: Urinary tract or genital infections, fatigue, or dehydration

• Rare but serious: Lactic acidosis (from Metformin) or severe allergic reactions

• Seek medical attention if you experience severe weakness, shortness of breath, or muscle pain

Precautions:

• Take with food to minimize stomach upset

• Stay hydrated and avoid excessive alcohol

• Regularly monitor blood sugar, kidney function, and electrolytes

• Not recommended for Type 1 Diabetes or severe renal impairment

• Use under medical supervision, especially in elderly or cardiac patients